18F-EF5

N/A

Report date: 2025/12/01 17:52:10

Base Information

Drug Name18F-EF5
Drug Alias NameFluorine-F18EF5[18F]EF-5CEN-109
ClassificationSmall moleculesDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsHemangiopericytomaMeningiomaSquamous Cell Carcinoma of Head and Neck +[19] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFinland
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStanford UniversityTurku University HospitalNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsHemangiopericytomaMeningiomaSquamous Cell Carcinoma of Head and Neck +[19] 

Other Information

ATC CodeN/A
Related LinksWikipedia